Economic Evaluation of Selective Neonatal Bacillus Calmette-Guérin Vaccination of High-risk Infants in Ireland-Reference-Cited by-同舟云学术

Economic Evaluation of Selective Neonatal Bacillus Calmette-Guérin Vaccination of High-risk Infants in Ireland

Published:2018-08 Issue:8 Volume:37 Page:759-767
ISSN:0891-3668
Container-title:Pediatric Infectious Disease Journal
language:en
Short-container-title:

Author:

Teljeur Conor,Moran Patrick S.,Harrington Patricia,Butler Karina,Corcoran Brenda,O’Donnell Joan,Usher Cara,O’Flanagan Darina,Connolly Kevin,Ryan Máirín

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Microbiology (medical),Pediatrics, Perinatology and Child Health

Reference30 articles.

1. Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guérin vaccination against tuberculosis.;Abubakar;Health Technol Assess,2013

2. Preventing tuberculosis with bacillus Calmette-Guérin vaccine: a meta-analysis of the literature.;Brewer;Clin Infect Dis,2000

3. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature.;Colditz;JAMA,1994

4. The BCG World Atlas: a database of global BCG vaccination policies and practices.;Zwerling;PLoS Med,2011

5. A review of the literature on the economics of vaccination against TB.;Tu;Expert Rev Vaccines,2012

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retrospective cohort study exploring the impact of universal Tuberculosis (TB) vaccination cessation on the epidemiology of paediatric TB in Ireland, 2011–2021;Vaccine;2024-03

2. Cost-Effectiveness Analysis of BCG Vaccination against Tuberculosis in Indonesia: A Model-Based Study;Vaccines;2020-11-26

3. Health economic evaluation of current vaccination strategies and new vaccines against tuberculosis: a systematic review;Expert Review of Vaccines;2019-08-12

4. Impact of BCG vaccination on incidence of tuberculosis disease in southern Ireland;BMC Infectious Diseases;2019-05-09

5. Selective neonatal BCG vax − a cost-effective option in Ireland?;PharmacoEconomics & Outcomes News;2018-02